'Pragmatic randomized controlled trial of individually prescribed exercise versus usual care in a heterogeneous cancer survivor population': a feasibility study PEACH trial: prescribed exercise after chemotherapy

Julie M Walsh, Juliette Hussey, Emer Guinan, Dearbhaile O' Donnell, Julie M Walsh, Juliette Hussey, Emer Guinan, Dearbhaile O' Donnell

Abstract

Background: Many cancer survivors suffer a range of physical and psychological symptoms which may persist for months or years after cessation of treatment. Despite the known benefits of exercise and its potential to address many of the adverse effects of treatment, the role of exercise as well as optimum duration, frequency, and intensity in this population has yet to be fully elucidated. Many cancer rehabilitation programmes presented in the literature are very long and have tight eligibility criteria which make them non-applicable to the majority of cancer survivors. This paper presents the protocol of a novel 8-week intervention which aims to increase fitness, and address other physical symptoms in a heterogeneous cancer survivor population.

Methods/design: The aim is to recruit 64 cancer survivors 2-6 months after completion of chemotherapy, usually adjuvant, with curative intent. Subjects will be recruited through oncology clinics in a single institution and randomised to usual care or an exercise intervention. The exercise intervention consists of two specifically tailored supervised moderate intensity aerobic exercise sessions weekly over 8-weeks. All participants will be assessed at baseline (0 weeks), at the end of the intervention (8 weeks), and at 3-month follow-up. The primary outcome measure is fitness, and secondary patient-related outcome measures include fatigue, quality of life, and morphological outcomes. A further secondary outcome is process evaluation including adherence to and compliance with the exercise program.

Discussion: This study will provide valuable information about the physical outcomes of this 8-week supervised aerobic programme. Additionally, process information and economic evaluation will inform the feasibility of implementing this program in a heterogeneous population post cessation of chemotherapy.

Trial registration: ClinicalTrials.gov NCT01030887.

References

    1. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, Heath GW, Thompson PD, Bayman A. Physical activity and public health: updated recommendations for adultrs from the American College of sports medicine and the American Heart Association. Circulation. 2007;116:1081–1093. doi: 10.1161/CIRCULATIONAHA.107.185649.
    1. Nelson ME, Rejeski WJ, N BS, Duncan PW, Judge JO, King AC, Macera CA, Castaneda-Sceppa C. Physical activity and public health in older adults: recommendation from the American College of Sports medicine and the American Heart Association. Circulation. 2007;116:1094–1105. doi: 10.1161/CIRCULATIONAHA.107.185650.
    1. Ford ES, Kohl HW, Mokdad AH, Ajani UA. Sedentary behaviour, physical activity, and the metabolic syndrome among U. S. adults. Obesity Research. 2005;13:608–614. doi: 10.1038/oby.2005.65.
    1. Jakes RW, Day NE, Khaw KT, Luben R, Oakes S, Welch A, Bingham S, Wareham NJ. Television viewing and low participation in vigorous recreation are independently assoctiated with obesity and markers of cardiovascular disease risk:EPIC-Norfolk population-based study. European Journal of Clinical Nutrition. 2003;57:1089–1096. doi: 10.1038/sj.ejcn.1601648.
    1. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006;24:3527–3534. doi: 10.1200/JCO.2006.06.0855.
    1. Meyerhardt JA, Heseltine D, Niedziecki D, Hollis D, Saltz LB, Mayer RJ, Thomas J, Nelson H, Whittom R, Hantel A. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALBG 89803. J Clin Oncol. 2006;24:3535–3541. doi: 10.1200/JCO.2006.06.0863.
    1. Hayes SC, Spence RR, Galvao DA, Newton RU. Australian Association for Exercise and Sport Science position stand: Optimising cancer outcomes through exercise. J Sci Med Sport. 2009;12:428–434. doi: 10.1016/j.jsams.2009.03.002.
    1. Bines J, Gradishar WJ. Primary care issues for the breast cancer survivor. Compr Ther. 1997;23:605–611.
    1. Ganz PA, Desmond KA, Leedham B. Quality-of-life on long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst. 2002;94:39–49.
    1. Ganz PA, Guadagnoli E, Landrum MB, Lash TL, Rakowski W, Silliman RA. Breast cancer in older women: Quality of life and psychological adjustment in the 15 months after diagnosis. J Clin Oncol. 2003;21:4027–4033. doi: 10.1200/JCO.2003.08.097.
    1. Avis NE, Crawford S, Manuel J. Quality of life among younger women with breast cancer. J Clin Oncol. 2005;23(15):322–330. doi: 10.1200/JCO.2005.05.130.
    1. Loescher LJ, Welch-Mc Caffret D, Leigh SA. Surviving adult cancers. Part 1: Physiological effects. Ann Intern Med. 1989;111:411–432.
    1. Cardinale D, Sandri MT, Marinoni A. Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy. Ann Oncol. 2002;13:710–715. doi: 10.1093/annonc/mdf170.
    1. Taghian AG, Assaad SI, Niemierko A. Risk of pneumonitis in braest cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst. 2001;93:1806–1811. doi: 10.1093/jnci/93.23.1806.
    1. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med. 2001;344:1997–2008. doi: 10.1056/NEJM200106283442607.
    1. Zabora J, K B, Curbow B. The prevalence of psycjhological distress by cancer site. Psychooncology. 2001;10:19–28. doi: 10.1002/1099-1611(200101/02)10:1<19::AID-PON501>;2-Y.
    1. Perez EA, Suman VJ, Davidson NE. Effect of doxorubicrin plus cyclophoamide on left ventricular ejection fraction in patients with breast cancer in teh North Central Cancer Treatment Group N9831 Intergroup Adjuvant Trial. J Clin Oncol. 2004;22:3700–3704. doi: 10.1200/JCO.2004.03.516.
    1. Jensen BV, Skovsgaard T, Nielsen SL. Functional monitoring of antracycline cardiotoxicity: A prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol. 2002;13:699–709. doi: 10.1093/annonc/mdf132.
    1. Beisecker A, Cook MR, Ashworth J. Side effects of adjuvant chemotherapy: Perceptions of node-negative breast cancer patients. Psychooncology. 1997;6:85–93. doi: 10.1002/(SICI)1099-1611(199706)6:2<85::AID-PON247>;2-K.
    1. deJong N, Courtens AM, Abu-Saad HH. Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nurs. 2002;25:283–297. doi: 10.1097/00002820-200208000-00004.
    1. Courneya KS, Friedenreich CM. Relationship between exercise pattern across the cancer experience and current quality of life in colorectal cancer survivors. J Altern Complement Med. 1997;3:215–226. doi: 10.1089/acm.1997.3.215.
    1. Courneya KS, Friedenreich CM. Relationship between exercise during treatment and current quality of life among survivors of breast cancer. J Psycho Oncol. 1997;15:35–57. doi: 10.1300/J077v15n03_02.
    1. Cella D, Tulsky DS. Measuring quality of life today: Methodological aspects. Oncology. 1990;14:101–108.
    1. Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM, Fagoaga OR, Nehlsen-Cannarella SL. Moderate exercise training and natural killer cell cytotoxix activity in breast cancer patients. Int J Sports Med. 1995;16:334–337. doi: 10.1055/s-2007-973015.
    1. Stoll BA. Diet and exercise regimens to improve breast carcinoma prognosis. Cancer. 1996;78:2465–2470. doi: 10.1002/(SICI)1097-0142(19961215)78:12<2465::AID-CNCR3>;2-J.
    1. Courneya KS. Exercise interventions during cancer treatment: biopsychosocial outcomes. Exerc Sport Sci Rev. 2001;29:60–64. doi: 10.1097/00003677-200104000-00004.
    1. Segal R, W E, Johnsin D. Structured exercise improves physical functioning in women with stages I and II braest cancer: results of a randomized controlled trial. J Clin Oncol. 2001;19:657–665.
    1. Drake D, Falzer P, Xistris D, Robinson G, Roberge M. Physical firness training: outcomes for adult oncology patients. Clin Nurs Res. 2004;13:657–665. doi: 10.1177/1054773804265673.
    1. Dimeo FC, Stieglitz RD, Novelli-Fischer U, Fetscher S, Keul J. Effects of physical activity on the fatigue and physiologic status of cancer patients during chemotherapy. Cancer. 1999;85:2273–2277. doi: 10.1002/(SICI)1097-0142(19990515)85:10<2273::AID-CNCR24>;2-B.
    1. Mc Tiernan A. Physical Activity after Cancer: Physiologic Outcomes. Cancer Investigation. 2004;22(1):68–81. doi: 10.1081/CNV-120027581.
    1. Pate RRM, Pratt SN, Blair WL, Haskell CA, Macera C. Physical activity and public health: recommendation from the Centres for Disease Control and Prevention and the American College of Sports medicine. J A M A. 1995;273:402–407. doi: 10.1001/jama.273.5.402.
    1. Bellizzi KM, Rowland JH, Jeffery DD, Mc Neel T. Health behaviours of cancer survivors: examining opportunities for cancer control intervention. J Clin Oncol. 2005;23:8884–8893. doi: 10.1200/JCO.2005.02.2343.
    1. Irwin ML, Crumlet D, Mc Tiernan A. Physical activity levels before and after a diagnosis of breast carcinoma: the Health, Eating, Activity (HEAL) study. Cancer. 2003;97(7):1746–1757. doi: 10.1002/cncr.11227.
    1. Irwin M, McTiernan A, Bernstein L, Gilliland FD, Baumgartner R, Ballard-Barbash R. Physical Activity Levels among Breast Cancer Survivors. Medicine & Science in Sports & Exercise. 2004;36(9):1484–1491.
    1. Wilmoth MC, Coleman EA, C SS, Davis C. Fatigue, weight gain, and altered sexuality in patients with breast cancer: exploration of a symptom cluster. Oncol Nurs Forum. 2004;31:1069–1075. doi: 10.1188/04.ONF.1069-1075.
    1. Adamsen LM, Quist M, Andersen C, Møller T, Herrstedt J, Kronborg D, Baadsgaard MK, Vistisen K, Midtgaard J, Christiansen B. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ. 2009;339(3410)
    1. Fletcher GF, Balady GJ, Amsterdam EA, Chaitman B, Eckel R, Fleg J, Froelicher VF, Leon AS, Pina IL, Rodney R. Exercise Standards for Testing and Training. A Statement for Healthcare Professionals from the American Heart Association. Circulation. 2001;104:1694–1740. doi: 10.1161/hc3901.095960.
    1. American College of Sports Medicine. ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription. 6. Philadelphia: Lippincott Williams & Wilkins; 2009.
    1. Noonan V, Dean E. Submaximal Exercise Testing: Clinical Application and Interpretation. Phys Ther. 2000;80(8):782–807.
    1. Bennett JA, Winters-Stone K, Nail L. Conceptualizing and measuring physical functioning in cancer survivorship studies. Oncol Nurs Forum. 2006;33:41–49. doi: 10.1188/06.ONF.41-49.
    1. Cella D, Eton DT, S LJ. Combining anchor and distribution based methods to derive clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scales. J Pain Symptom Manage. 2002;24:547–561. doi: 10.1016/S0885-3924(02)00529-8.
    1. Cella D, Tulsky DS, Gray G, Sarafin B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J. The Functional Assessment of Cancer Therapy Scale: Development and Validation of the General Measure. Journal of Clinical Oncology. 1993;1993(11):570–579.
    1. Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res. 2002;11:207–221. doi: 10.1023/A:1015276414526.
    1. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey. Manual and interpretation guide. Boston: The Health institute, New England Medical Center; 1993.
    1. Godin G, Shephard RJ. A simple method to assess exercise behaviour in the community. Can J Appl Sports Sci. 1985;10:141–146.
    1. Powell SMP, Rowlands AV. Inter-monitor variability of the RT3 accelerometer during a variety of physical activities. Med Sci Sports Exerc. 2004;36:324–330. doi: 10.1249/01.MSS.0000113743.68789.36.
    1. Rowlands AV, Thomas PWM, Eston RG, Topping R. Validation of the RT3 Triaxial Accelerometer for the Assessment of Physicak Activity. Med Sci Sports Exerc. 2004;36(3):518–524. doi: 10.1249/01.MSS.0000117158.14542.E7.
    1. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: Centre on Outcomes, Research and Education (CORE), Ecanston Northwestern Healthcare and Northwestern University, 1997. 1997.
    1. Cella D. The functional assessment of cancer therapy-anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol. 1997;34(3 Suppl 2):13–19.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa